Rubaiya Anika | Health | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

Rubaiya Anika
Mount Sinai Hospital, United States

Rubaiya Anika
Affiliation Mount Sinai Hospital
Country United States
Documents 1
Subject Area Health
Event International Research Hypothesis Excellence Award
ORCID 0009-0005-9072-732X

Rubaiya Anika is a researcher affiliated with Mount Sinai Hospital in the United States whose documented research contribution addresses environmental exposure and biological aging. Her listed journal article examines urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration among U.S. adults using data from the National Health and Nutrition Examination Survey (NHANES) covering 1999–2018. The work was published in the International Journal of Environmental Research and Public Health in August 2026 and provides a research contribution at the intersection of environmental health, exposure science, epidemiology, and aging research. [1]

Abstract

The research contribution associated with Rubaiya Anika investigates the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration in U.S. adults. The study, titled Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018, uses population-based NHANES data to examine an environmental exposure question within an aging-related epidemiological framework. The article was published in the International Journal of Environmental Research and Public Health in August 2026 and is identified by DOI 10.3390/ijerph23091126. [1]

Keywords

  • Innovative Research Award
  • Rubaiya Anika
  • Organophosphate metabolites
  • Phenotypic aging
  • Environmental health

Introduction

Environmental exposures are an important area of public-health research because chemical exposures may vary across populations and may be investigated in relation to measurable biological and health outcomes. Organophosphate metabolites measured in urine can serve as biomarkers of exposure to organophosphate compounds, while phenotypic measures of aging can provide quantitative indicators for studying biological aging in epidemiological populations. The reported study brings these concepts together by analyzing nationally collected U.S. health data across multiple NHANES cycles from 1999 through 2018. [1]

Research Profile

Rubaiya Anika is identified in the supplied publication record as an author affiliated with Mount Sinai Hospital, United States. The documented subject area is Health, with the research contribution positioned within environmental and population health. The available publication record contains one indexed document supplied for this recognition profile.[1]

Research Contributions

The principal documented contribution is the study of urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration. This research connects environmental exposure assessment with an aging-related outcome and uses nationally collected health-survey data as its analytical foundation. [1]

  • Evaluation of urinary organophosphate metabolite measurements as indicators of environmental exposure.
  • Investigation of phenotypic aging acceleration as a measurable aging-related outcome.
  • Use of NHANES data spanning 1999–2018 to support population-based analysis.
  • Integration of environmental epidemiology and biological aging research.[1]

Publications

The available record identifies one journal article associated with Rubaiya Anika:

Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018

The publication lists Rubaiya Anika, Matthew Untalan, Emanuela Taioli, and Stephanie Tuminello as contributors. The DOI provides a persistent identifier for the journal article and supports direct access to its bibliographic record. [1]

Research Impact

The documented research has potential relevance to environmental and population health because it investigates whether measurable environmental exposure biomarkers are associated with an aging-related phenotype in adults. Research of this type can contribute to hypothesis generation, exposure surveillance, and the identification of questions that may warrant further investigation through longitudinal, mechanistic, or experimental studies. [1]

Award Suitability

The documented publication provides a substantive basis for considering Rubaiya Anika for recognition under an Innovative Research Award framework. The work applies an interdisciplinary research approach by connecting environmental exposure biomarkers with a quantitative indicator of phenotypic aging in a U.S. adult population. [1]

  • Research innovation: The study links environmental exposure assessment with laboratory-derived phenotypic aging measures.
  • Interdisciplinary relevance: The research spans environmental health, epidemiology, exposure science, and aging research.
  • Population relevance: NHANES provides a nationally collected U.S. population dataset for epidemiological investigation.
  • Research communication: The work is documented through a peer-reviewed journal publication with a persistent DOI.
  • Future research value: The findings can help motivate additional research into environmental determinants of biological aging.

Conclusion

Rubaiya Anika’s documented research contribution focuses on the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration among U.S. adults using NHANES data from 1999–2018. The resulting publication demonstrates an interdisciplinary approach to environmental and population health research and provides a basis for further investigation of environmental influences on aging-related outcomes. [1]

References

  1. Anika, R., Untalan, M., Taioli, E., & Tuminello, S. (2026). Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018. International Journal of Environmental Research and Public Health, 23(9), 1126.
    https://doi.org/10.3390/ijerph23091126

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Published on by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

 

Tatsuya Nakanowatari | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Tatsuya Nakanowatari | Medicine and Health Sciences | Best Researcher Award

Dr Tatsuya Nakanowatari, Fukushima Medical University, Japan

Based on Dr. Tatsuya Nakanowatari’s impressive academic background and research achievements, he appears to be a strong candidate for the Best Researcher Award. Below is a summary of his accomplishments:

Publication profile

Scopus

Education and Training

Dr. Nakanowatari holds a PhD in Physiotherapy from the University of Newcastle, Australia (2023) and a Master’s degree in Disability Sciences from Tohoku University Graduate School of Medicine (2011). He also has a BS in Physical Therapy from Yamagata Prefectural University of Health Science (2004).

Research and Publications

  1. Loading Asymmetry as a Predictor of Frailty (2024) In a study published in Sensors, Dr. Nakanowatari and colleagues used in-shoe sensors to assess gait asymmetry in community-dwelling older adults. The research identified loading asymmetry as a potential predictor of frailty, a crucial finding for fall prevention and early diagnosis in aging populations.
  2. Detecting Limb Load Asymmetry (2023) In Gait Posture, Dr. Nakanowatari examined limb load asymmetry between fallers and non-fallers among older adults using in-shoe sensors. The study highlighted significant gait differences that can aid in predicting fall risk in elderly individuals, a critical area in physical rehabilitation.
  3. Plantar Force Variation during Treadmill Walking (2024) His preliminary study in Biomedical Human Kinetics explored the effects of walking speed on plantar forces across different foot regions. The research employed force-sensing insoles and provided valuable insights into the biomechanical aspects of gait.
  4. Tensor Fasciae Latae Length and Leg Length Discrepancy (2022) In a study published in the Journal of Back and Musculoskeletal Rehabilitation, Dr. Nakanowatari examined the effect of shoe lifts on the tensor fasciae latae using ultrasonic elastography. The findings contributed to understanding how artificial leg length discrepancies impact musculoskeletal health.
  5. Insular Lesion and Perception of Noxious Stimulation (2022) Published in Internal Medicine, this case study involved a patient with a unilateral insular lesion exhibiting bilaterally reduced pain perception. The research provided deeper insight into the neurological mechanisms behind pain perception and the impact of brain lesions.

Conclusion

Dr. Nakanowatari’s research primarily focuses on biomechanics, frailty, and neuromuscular health in older adults. His innovative use of sensor technology for gait analysis and muscle function assessment positions him as an influential figure in physical therapy research. His work is not only advancing scientific understanding but also making practical contributions to improving patient outcomes, making him a strong contender for the Best Researcher Award.

Publication top notes

In-Shoe Sensor Measures of Loading Asymmetry during Gait as a Predictor of Frailty Development in Community-Dwelling Older Adults

Effects of speed on plantar forces in three-foot regions during treadmill walking: A preliminary study using force sensing insoles

Detecting differences in limb load asymmetry during walking between older adult fallers and non-fallers using in-shoe sensors

The effect of a shoe lift on tensor fasciae latae length during standing with an artificial functional leg length discrepancy: An ultrasonic shear wave elastography study

A Case of Supernumerary Phantom Limb and Suspected Posterior Alien Hand Syndrome after Pontine Hemorrhage